News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (208)
2 (92)
4 (7)
5 (167)
6 (192)
7 (172)
8 (177)
9 (73)
10 (39)
11 (36)
12 (204)
13 (174)
14 (134)
15 (167)
16 (74)
18 (3)
19 (175)
20 (146)
21 (138)
22 (109)
23 (39)
24 (2)
25 (3)
26 (3)
27 (42)
28 (46)
29 (40)
30 (19)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Pharm Country
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy
IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the third and final part of its New Drug Application (NDA) for rolling review of avacincaptad pegol (ACP), a novel investigational complement C5 inhibitor for the treatment of geographic atrophy (GA) secondary to Age-Related Macular Degeneration (AMD).
December 20, 2022
·
7 min read
Business
Venatorx Pharmaceuticals Announces Organizational Changes
Venatorx Pharmaceuticals today announced two organizational changes: the retirement of its Chief Medical Officer, Timothy Henkel, M.D., Ph.D., and the step-down of Vincent Milano from the Board of Directors.
December 20, 2022
·
2 min read
Business
KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance
KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc.
December 20, 2022
·
5 min read
KBI Biopharma, Inc. Secures Swissmedic Regulatory Establishment License for State-of-the-Art Mammalian Cell Manufacturing Facility in Geneva
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced its recently expanded, state-of-the-art Geneva mammalian cell manufacturing facility has obtained a Swissmedic regulatory establishment license.
December 20, 2022
·
2 min read
Sunshine Biopharma’s Annual Letter to Shareholders - December 20, 2022
Sunshine Biopharma Inc., a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals issued a letter to shareholders from Dr. Steve Slilaty, Chairman and CEO of the Company.
December 20, 2022
·
5 min read
Biotech Bay
Quantum Leap Healthcare Collaborative Announces Positive Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL in Neoadjuvant Breast Cancer
Quantum Leap Healthcare Collaborative (QLHC) today announced that a regimen including oral paclitaxel plus encequidar (Athenex) in combination with a PD-1 inhibitor and carboplatin has graduated in the triple-negative subset of high-risk early-stage breast cancer.
December 20, 2022
·
2 min read
Pharm Country
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval.
December 20, 2022
·
6 min read
UPLIZNA® (inebilizumab-cdon) Approved in Brazil for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.
December 20, 2022
·
9 min read
Pharm Country
Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First Next-Generation Single-Molecule Protein Sequencing Platform
Quantum-Si Announces Commercial Availability of Platinum TM , the World’s First Next-Generation Single-Molecule Protein Sequencing Platform.
December 20, 2022
·
9 min read
Business
Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Board
Nascent Biotech, Inc. announced today that Dr. Ivan Babic, a renowned cancer expert, has been appointed to the Company’s scientific advisory board.
December 20, 2022
·
2 min read
Previous
3 of 15
Next